Related Experiment Video
Updated: Jul 28, 2025

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.5K
Melanoma Tumor Depth Quality Audit: A Nonmatch Analysis
Pamela Sanchez1, Margaret Peggy Adamo1, Clara J K Lam1
1Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.
Journal of Registry Management
|June 1, 2023
Summary
An algorithm was developed to identify melanoma tumor depth, finding 24% of cases had discrepancies. This tool can improve cancer registry data quality by flagging errors for review.
Area of Science:
- Oncology
- Cancer Surveillance Research
- Medical Informatics
Background:
- Concerns arose regarding melanoma tumor depth coding within the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program.
- The Surveillance Research Program (SRP) initiated efforts to address these coding inconsistencies.
Purpose of the Study:
- To develop and validate an algorithm for accurately identifying melanoma tumor depth measurements.
- To assess the accuracy of existing melanoma depth coding practices through a nonmatch analysis.
Main Methods:
- A natural language processing algorithm was developed to extract melanoma tumor depth values.
- A nonmatch analysis compared algorithm-identified values against a gold standard using 1,117 cancer cases (2010-2017).
- Statistical analyses were performed using SAS software (version 9.4) to evaluate discrepancies and their distribution.
Main Results:
- 76% of cases showed a match between originally reported and gold standard melanoma depth values.
- 16% of cases had incorrect AJCC-7 T staging based on original reporting, often misclassified as TX instead of T1.
- Overall, 24% of cases exhibited discrepancies in recorded melanoma depth, with decimal errors accounting for 3%.
Conclusions:
- A significant portion of melanoma cases (24%) had coding discrepancies in tumor depth.
- The developed algorithm can enhance cancer registry data quality by automating the identification of inconsistencies.
- Automated review and adjudication by registrars can optimize resource allocation and improve data accuracy.

